Elastin stabilization of connective tissue

(19)

(11)

EP 2 460 525 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	14.09.2016 Bulletin 2016/37

(45)	Mention of the grant of the patent:
	13.07.2016 Bulletin 2016/28

(21)	Application number: 11181250.9

(22)	Date of filing: 07.04.2006

(51)

International Patent Classification (IPC):

A61K 31/7024^(2006.01)
A61P 9/14^(2006.01)

A61F 2/00^(2006.01)

(54)	Elastin stabilization of connective tissue Elastinstabilisierung von Bindegewebe Stabilisation d'élastine de tissu conjonctif

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

(30)

Priority:

25.04.2005 US 674631 P
23.03.2006 US 387454

(43)	Date of publication of application:
	06.06.2012 Bulletin 2012/23

(62)	Application number of the earlier application in accordance with Art. 76 EPC:
	06758289.0 / 1874223

(73)	Proprietor: CURF Clemson University Research Foundation
	Anderson, SC 29625 (US)

(72)	Inventors:
	Vyavahare, Narendra R. Easley, South Carolina 29642 (US) Isenburg, Jason C. Victoria, Minnesota 55386 (US) Simionescu, Dan T. Central, South Carolina 29630 (US)

(74)	Representative: dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB
	Deichmannhaus am Dom Bahnhofsvorplatz 1 50667 Köln 50667 Köln (DE)

(56)

References cited: :

EP-A- 0 617 964
GB-A- 2 057 437

WO-A-2004/047620
US-B1- 6 437 004

ISENBURG J C ET AL: "Tannic acid treatment enhances biostability and reduces calcification of glutaraldehyde fixed aortic wall", BIOMATERIALS, ELSEVIER SCIENCE PUBLISHERS BV., BARKING, GB, vol. 26, no. 11, 1 April 2005 (2005-04-01) , pages 1237-1245, XP025280361, ISSN: 0142-9612, DOI: 10.1016/J.BIOMATERIALS.2004.04.034 [retrieved on 2005-04-01]

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).